74 related articles for article (PubMed ID: 7478404)
1. Radiolabelled peptides: now and the future.
Thakur ML
Nucl Med Commun; 1995 Sep; 16(9):724-32. PubMed ID: 7478404
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
[TBL] [Abstract][Full Text] [Related]
3. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.
Bartholomä M; Valliant J; Maresca KP; Babich J; Zubieta J
Chem Commun (Camb); 2009 Feb; (5):493-512. PubMed ID: 19283279
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
6. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m labeling of DNA oligonucleotides.
Hnatowich DJ; Winnard P; Virzi F; Fogarasi M; Sano T; Smith CL; Cantor CR; Rusckowski M
J Nucl Med; 1995 Dec; 36(12):2306-14. PubMed ID: 8523124
[TBL] [Abstract][Full Text] [Related]
8. Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: synthesis and characterization.
Mansi R; Tesauro D; De Capua A; Fattorusso R; Caracò C; Aloj L; Benedetti E; Morelli G
Biopolymers; 2004; 76(6):527-34. PubMed ID: 15526334
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent.
Karra SR; Schibli R; Gali H; Katti KV; Hoffman TJ; Higginbotham C; Sieckman GL; Volkert WA
Bioconjug Chem; 1999; 10(2):254-60. PubMed ID: 10077475
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new bivalent peptides for applications in the Affinity Enhancement System.
Morandeau L; Benoist E; Loussouarn A; Ouadi A; Lesaec P; Mougin M; Faivre-Chauvet A; Le Boterff J; Chatal JF; Barbet J; Gestin JF
Bioconjug Chem; 2005; 16(1):184-93. PubMed ID: 15656590
[TBL] [Abstract][Full Text] [Related]
11. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
Maina T; Nock BA; Zhang H; Nikolopoulou A; Waser B; Reubi JC; Maecke HR
J Nucl Med; 2005 May; 46(5):823-30. PubMed ID: 15872357
[TBL] [Abstract][Full Text] [Related]
12. Current use and future potential of organometallic radiopharmaceuticals.
Schibli R; Schubiger PA
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1529-42. PubMed ID: 12397472
[TBL] [Abstract][Full Text] [Related]
13. [Methods of leukocyte radionuclide labeling and the potentials for using labelled leukocytes in medicine].
Vorob'eva EN
Med Radiol (Mosk); 1981 Nov; 26(11):81-6. PubMed ID: 7033713
[No Abstract] [Full Text] [Related]
14. Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
Giblin MF; Veerendra B; Smith CJ
In Vivo; 2005; 19(1):9-29. PubMed ID: 15796153
[TBL] [Abstract][Full Text] [Related]
15. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.
Okarvi SM
Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeling of antibodies.
Eckelman WC; Paik CH; Reba RC
Cancer Res; 1980 Aug; 40(8 Pt 2):3036-42. PubMed ID: 7397697
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in 99Tcm-labelled peptide-based radiopharmaceuticals: an overview.
Okarvi SM
Nucl Med Commun; 1999 Dec; 20(12):1093-112. PubMed ID: 10664991
[TBL] [Abstract][Full Text] [Related]
18. Peptides, multimers and polymers.
Dijkraaf I; Wester HJ
Handb Exp Pharmacol; 2008; (185 Pt 2):61-92. PubMed ID: 18626599
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte kinetics and methods of evaluating cell performance.
Peters AM
Nucl Med Commun; 1988 Oct; 9(10):687-92. PubMed ID: 3062506
[No Abstract] [Full Text] [Related]
20. Radiolabelled human immunoglobulins.
Buscombe J
Nucl Med Commun; 1995 Dec; 16(12):990-1001. PubMed ID: 8719979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
